OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings
Hodaka Yamada, Masashi Yoshida, Shunsuke Funazaki, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 4, pp. 176-176
Open Access | Times Cited: 20
Hodaka Yamada, Masashi Yoshida, Shunsuke Funazaki, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 4, pp. 176-176
Open Access | Times Cited: 20
Showing 20 citing articles:
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study
Benedetta Maria Bonora, Giuseppina Russo, Frida Leonetti, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1395-1403
Open Access | Times Cited: 8
Benedetta Maria Bonora, Giuseppina Russo, Frida Leonetti, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1395-1403
Open Access | Times Cited: 8
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3054-3054
Open Access | Times Cited: 6
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3054-3054
Open Access | Times Cited: 6
Daisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 11, pp. 1566-1577
Open Access | Times Cited: 6
Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence
Awadhesh Kumar Singh, Ritu Singh, Akriti Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 5, pp. 103024-103024
Closed Access | Times Cited: 4
Awadhesh Kumar Singh, Ritu Singh, Akriti Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 5, pp. 103024-103024
Closed Access | Times Cited: 4
Ryo Suzuki, Hanan Amadid, Atheline Major‐Pedersen, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 8, pp. 1047-1056
Open Access | Times Cited: 4
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1963-1977
Open Access | Times Cited: 3
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1963-1977
Open Access | Times Cited: 3
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care
Mario Luca Morieri, Riccardo Candido, Simona Frontoni, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 2159-2172
Open Access | Times Cited: 10
Mario Luca Morieri, Riccardo Candido, Simona Frontoni, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 2159-2172
Open Access | Times Cited: 10
Real‐world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2S‐RWD )
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 4, pp. 1519-1523
Open Access | Times Cited: 6
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 4, pp. 1519-1523
Open Access | Times Cited: 6
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics
Tetsuaki Inokuchi, Yoshihide Fukumoto, Gendai Lee, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 9, pp. 1202-1210
Open Access | Times Cited: 1
Tetsuaki Inokuchi, Yoshihide Fukumoto, Gendai Lee, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 9, pp. 1202-1210
Open Access | Times Cited: 1
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis
Yuna Chae, Sun‐Hong Kwon, Jin Hyun Nam, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 8, pp. 721-729
Closed Access | Times Cited: 1
Yuna Chae, Sun‐Hong Kwon, Jin Hyun Nam, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 8, pp. 721-729
Closed Access | Times Cited: 1
Tendências atuais na eficácia e segurança da Semaglutida no controle glicêmico de pacientes diabéticos: Revisão de literatura
Alyne Werner Mota Pereira, Júlia Andrade Pereira, S. Ferreira
Research Society and Development (2024) Vol. 13, Iss. 7, pp. e11013746426-e11013746426
Open Access | Times Cited: 1
Alyne Werner Mota Pereira, Júlia Andrade Pereira, S. Ferreira
Research Society and Development (2024) Vol. 13, Iss. 7, pp. e11013746426-e11013746426
Open Access | Times Cited: 1
Real-world Evidence on Oral Semaglutide for the Management of Type 2 Diabetes. A Narrative Review for Clinical Practice
Massimo Marassi, Gian Paolo Fadini
Clinical Therapeutics (2024)
Open Access | Times Cited: 1
Massimo Marassi, Gian Paolo Fadini
Clinical Therapeutics (2024)
Open Access | Times Cited: 1
Efficacy and Safety of Oral Semaglutide in Managing Type 2 Diabetes in India: A Real-World Study
Saswati Ray, Aparajita Ray, Siddhartha Goutam, et al.
Clinical Diabetology (2024) Vol. 13, Iss. 6, pp. 323-330
Open Access | Times Cited: 1
Saswati Ray, Aparajita Ray, Siddhartha Goutam, et al.
Clinical Diabetology (2024) Vol. 13, Iss. 6, pp. 323-330
Open Access | Times Cited: 1
Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus
Chihiro Yoneda, Junji Kobayashi, Nobuichi Kuribayashi
Diabetology International (2024) Vol. 15, Iss. 3, pp. 569-576
Closed Access
Chihiro Yoneda, Junji Kobayashi, Nobuichi Kuribayashi
Diabetology International (2024) Vol. 15, Iss. 3, pp. 569-576
Closed Access
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Emma Barrett, Gabrielle Ivey, Adam C. Cunningham, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Emma Barrett, Gabrielle Ivey, Adam C. Cunningham, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matching
Kazuki Aoyama, Yuya Nakajima, Shu Meguro, et al.
Diabetology International (2024) Vol. 15, Iss. 4, pp. 794-805
Closed Access
Kazuki Aoyama, Yuya Nakajima, Shu Meguro, et al.
Diabetology International (2024) Vol. 15, Iss. 4, pp. 794-805
Closed Access
Oral semaglutide improves glycemic control and lowers blood lipids: evidence from a real-world study
Dora Gašparini, Fabijan Čakanić, Tomislav Tufekčić, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 4
Open Access
Dora Gašparini, Fabijan Čakanić, Tomislav Tufekčić, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 4
Open Access
Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
Walter Baronti, Cristina Lencioni, Margherita Occhipinti, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111928-111928
Closed Access
Walter Baronti, Cristina Lencioni, Margherita Occhipinti, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111928-111928
Closed Access
Effectiveness of Oral Semaglutide in Management of Type 2 Diabetes: A Real-World Study from India
Aditya Dutta, Shama Mahendru, Rutuja Sharma, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 6, pp. 653-658
Open Access
Aditya Dutta, Shama Mahendru, Rutuja Sharma, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 6, pp. 653-658
Open Access
